Does SEMAGLUTIDE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.0% of all adverse event reports for SEMAGLUTIDE.
6
Reports of Malignant neoplasm progression with SEMAGLUTIDE
0.0%
of all SEMAGLUTIDE reports
1
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SEMAGLUTIDE?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SEMAGLUTIDE Alternatives Have Lower Malignant neoplasm progression Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B